Journal of Clinical Psychiatry Issue 78(7)

Mindfulness-Based Stress Reduction for Older Adults With Stress Disorders and Neurocognitive Difficulties: A Randomized Controlled Trial

Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers

Perceived Stigma and Quality of Life in Patients Following Recovery From Delirium

Vitamin D Deficiency Associated With Cognitive Functioning in Psychotic Disorders

Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial

Randomized, Double-Blind, Placebo-Controlled Trial of <em>N</em>-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder

Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial

Stimulant Treatment Trajectories Are Associated With Neural Reward Processing in Attention-Deficit/Hyperactivity Disorder

Psychotropic Medications in Swedish Homicide Victims and Offenders: A Forensic-Toxicological Case-Control Study of Adherence and Recreational Use

Expert Consensus Survey on Medication Adherence in Psychiatric Patients and Use of a Digital Medicine System

Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone

Insurance Coverage and Health Outcomes in Young Adults With Mental Illness Following the Affordable Care Act Dependent Coverage Expansion

A Risk Algorithm for the Persistence of Suicidal Thoughts and Behaviors During College

The Health-Promoting Effects of Insurance Coverage

A Case Report of Biotin Treatment for Valproate-Induced Hair Loss

Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Need for Further Analysis

Dr Brown and Colleagues Reply

Severity of Binge-Eating Disorder and Its Effects on Treatment Outcome

Dr Grilo Replies

A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer’s Disease

Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?

Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions

Incorporation of Mobile Application (App) Measures Into the Diagnosis of Smartphone Addiction

The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder

Sleep Disturbance Predicts Posttraumatic Stress Disorder and Depressive Symptoms: A Cohort Study of Chinese Adolescents

Introduction

Independent Effects of Apolipoprotein E and Cerebrovascular Burden on Later-Life Depression: The Wisconsin Longitudinal Study

Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study